@article{cbe522e712b54fcb88793afe3fff8fc5,
title = "In response to Dr. Knisely and colleagues",
author = "Vinai Gondi and Ranjini Tolakanahalli and Mehta, {Minesh P.} and Tom{\'e}, {Wolfgang A.}",
note = "Funding Information: Disclosures: Dr. Mehta has served as a consultant to Adnexus, Bayer, Genenteh, Merck, Schering Plough, and Tomotherapy; he serves on the Board of Directors of Pharmacyclics and as an advisor to Stemina, and is on the DSMB for Apogenix. He holds stock options in Pharmacyclics and Tomotherapy. Dr. Tome holds a research grant from Philips Radiation Oncology Systems and serves on the Scientific Advisory Board of Viewray, Inc . ",
year = "2011",
month = mar,
day = "1",
doi = "10.1016/j.ijrobp.2010.10.044",
language = "English (US)",
volume = "79",
pages = "958",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",
}
